STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
173
13F, latest reported quarter
Conversions, 180 days
11
Codes C/M, not in net · $791.1K priced
What the filings say about CRVL
Insiders, 180 days
-$18.8M net sold
6 sellers · 22% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$16.2M
6 notices
Corvel insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CORVEL CORP insiders sold a net $18.8M of stock across 374 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
43 earlier Form 4 trades (code P or S) here by this insider (43 sales), the last on Sep 11, 2026.
The trade is 0.7% of the 18,517,108 shares held after it.
2 other insiders sold within 30 days.
173 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider CORSTAR HOLDINGS INC sold about $9.0M of CRVL under a 10b5-1 plan on Sep 14, 2026, the largest insider sale at the company on our record; 2 other insiders sold within 30 days and 173 funds added in the latest 13F quarter.
42 earlier Form 4 trades (code P or S) here by this insider (42 sales), the last on Sep 4, 2026.
The trade is 0.2% of the 18,644,932 shares held after it.
2 other insiders sold within 30 days.
173 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider CORSTAR HOLDINGS INC sold about $2.1M of CRVL under a 10b5-1 plan on Sep 11, 2026; 2 other insiders sold within 30 days and 173 funds added in the latest 13F quarter.
41 earlier Form 4 trades (code P or S) here by this insider (41 sales), the last on Sep 3, 2026.
The trade is 0.1% of the 18,675,857 shares held after it.
2 other insiders sold within 30 days.
173 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider CORSTAR HOLDINGS INC sold about $999.6K of CRVL under a 10b5-1 plan on Sep 4, 2026; 2 other insiders sold within 30 days and 173 funds added in the latest 13F quarter.
40 earlier Form 4 trades (code P or S) here by this insider (40 sales), the last on Sep 8, 2025.
The trade is 0.3% of the 18,690,395 shares held after it.
2 other insiders sold within 30 days.
173 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider CORSTAR HOLDINGS INC sold about $3.6M of CRVL under a 10b5-1 plan on Sep 3, 2026; 2 other insiders sold within 30 days and 173 funds added in the latest 13F quarter.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Aug 27, 2026.
The trade is 3.6% of the 111,798 shares held after it.
2 other insiders sold within 30 days.
173 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director JESSUP R JUDD sold about $281.9K of CRVL on Sep 1, 2026; 2 other insiders sold within 30 days and 173 funds added in the latest 13F quarter.
374 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CRVL planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
CORSTAR HOLDINGS INC
Filed 2026-09-14
$9.0M
CORSTAR HOLDINGS INC
Filed 2026-09-11
$2.0M
CORSTAR HOLDINGS INC
Filed 2026-09-04
$996.3K
CORSTAR HOLDINGS INC
Filed 2026-09-03
$3.6M
JESSUP R JUDD
Filed 2026-08-24
$486.5K
CRVL mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Virtus KAR Small-Cap Core Fund
$49.3M position · as of 2026-06-30
2.7%
State Street(R) SPDR(R) S&P(R) Health Care Services ETF
$2.3M position · as of 2026-06-30
1.7%
Rockefeller US Small Cap Core Fund
$1.6M position · as of 2026-05-31
1.6%
First Trust SMID Growth Strength ETF
$310.0K position · as of 2026-06-30
1.1%
Invesco S&P SmallCap Health Care ETF
$1.3M position · as of 2026-05-31
1.0%
Boston Trust Walden Small Cap Fund
$9.5M position · as of 2026-06-30
0.9%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Michael G. Combs
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$1.3M
$472.2K
$594.7K
-14%
+25%
2024
$1.2M
$2.1M
$464.1K
+100%
-4%
2023
$967.0K
$1.9M
$485.1K
+156%
-15%
2022
$2.1M
$3.4M
$413.6K
+249%
+16%
2021
$1.4M
$4.5M
$482.7K
+209%
+24%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $18.8M sold by insiders over 180 days, 173 funds added last quarter, $16.2M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$983.7M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CRVL
FY Mar 2026
$958.5M
FY Mar 2025
$895.6M
FY Mar 2024
$795.3M
FY Mar 2023
$718.6M
FY Mar 2022
$646.2M
Jun 2026
$259.9M
Mar 2026
$248.5M
Dec 2025
$235.6M
Sep 2025
$239.6M
Jun 2025
$234.7M
Mar 2025
$231.5M
Dec 2024
$228.0M
Sep 2024
$224.4M
At each fiscal year end
Single quarter
Net margin, TTM
+11.7%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CRVL
FY Mar 2026
+11.5%
FY Mar 2025
+10.6%
FY Mar 2024
+9.6%
FY Mar 2023
+9.2%
FY Mar 2022
+10.3%
Jun 2026
+12.4%
Mar 2026
+12.5%
Dec 2025
+10.3%
Sep 2025
+11.6%
Jun 2025
+11.6%
Mar 2025
+11.4%
Dec 2024
+10.4%
Sep 2024
+10.4%
At each fiscal year end
Single quarter
Free cash flow, TTM
$113.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CRVL
FY Mar 2026
$110.3M
FY Mar 2025
$91.6M
FY Mar 2024
$70.0M
FY Mar 2023
$56.0M
FY Mar 2022
$37.4M
Jun 2026
$43.1M
Mar 2026
$20.3M
Dec 2025
$35.2M
Sep 2025
$15.3M
Jun 2025
$39.5M
Mar 2025
$14.3M
Dec 2024
$32.1M
Sep 2024
$12.4M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity CRVL
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt CRVL
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+30.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CRVL
FY Mar 2026
+30.8%
FY Mar 2025
+33.4%
FY Mar 2024
+33.9%
FY Mar 2023
+32.0%
FY Mar 2022
+30.7%
Jun 2026
+30.7%
Mar 2026
+30.8%
Dec 2025
+31.3%
Sep 2025
+32.6%
Jun 2025
+33.3%
Mar 2025
+33.4%
Dec 2024
+33.0%
Sep 2024
+32.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+17.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CRVL
FY Mar 2026
+18.6%
FY Mar 2025
+19.0%
FY Mar 2024
+18.0%
FY Mar 2023
+16.4%
FY Mar 2022
+15.8%
Jun 2026
+17.9%
Mar 2026
+18.6%
Dec 2025
+17.9%
Sep 2025
+18.6%
Jun 2025
+18.6%
Mar 2025
+19.0%
Dec 2024
+17.9%
Sep 2024
+17.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CRVL
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CRVL
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
37.28x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CRVL
FY Mar 2026
25.54x
FY Mar 2025
60.85x
FY Mar 2024
23.44x
FY Mar 2023
16.82x
FY Mar 2022
15.38x
Jun 2026
27.79x
Mar 2026
25.54x
Dec 2025
33.17x
Sep 2025
38.14x
Jun 2025
52.98x
Mar 2025
60.85x
Dec 2024
45.41x
Sep 2024
46.97x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value CRVL
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+2.7%
TTM free cash flow over market value at close 2026-10-23
FCF yield CRVL
FY Mar 2026
+3.9%
FY Mar 2025
+1.6%
FY Mar 2024
+4.7%
FY Mar 2023
+5.1%
FY Mar 2022
+3.8%
Jun 2026
+3.6%
Mar 2026
+3.9%
Dec 2025
+3.0%
Sep 2025
+2.5%
Jun 2025
+1.9%
Mar 2025
+1.6%
Dec 2024
+4.3%
Sep 2024
+3.9%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
2.33x
P/E over trailing EPS growth of 16%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing CRVL
FY Mar 2026
1.57x
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
5.12x
FY Mar 2022
0.36x
Jun 2026
1.74x
Mar 2026
1.57x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CRVL ranks highest on profitability (93rd percentile) and institutional and government (56th), and lowest on insider conviction (23rd), among Insurance peers.
Profitability
93
Inputs
Return on equity+30.7% · 86 pct, sector of 116
Return on assets+17.9% · 99 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Growth
51
Inputs
Revenue growth, YoY+7.0% · 43 pct, sector of 134
Backlog growth, YoY+8.9% · 58 pct, universe of 854
Insider conviction
23
Inputs
Net Form 4 buying (codes P and S), 180d-$3.2M · 45 pct, sector of 100
Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
56
Inputs
Funds adding, latest quarter173 · 56 pct, sector of 108
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
46
Inputs
Short interest, % of float+3.9% · 45 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+10.3% · 48 pct, sector of 110
2 not measured: Financial health, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CRVL filings, in plain words
Are Corvel insiders buying or selling CRVL?
In the 180 days to 2026-10-27, Corvel insiders were net sellers, a net $18.8M across purchases and sales reported on Form 4, by 6 sellers.
Are there planned insider sales of CRVL?
Yes. 6 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $16.2M of stock; the latest, by CORSTAR HOLDINGS INC, was filed 2026-09-14.
Read the full summary
In the 180 days to 2026-10-27, Corvel insiders were net sellers of CRVL, a net $18.8M across purchases and sales reported on Form 4 by 6 sellers. Most of that figure, $16.2M, came from a holder of 10% or more rather than an officer or director. 22% of the 18 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 6 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $16.2M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.